{"title": "PDF", "author": "PDF", "url": "iacc.hhs.gov/meetings/autism-events/2021/april28/remley-slides.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "the Autism Spectrum Karen Remley, MD, MBA, MPH, FAAP Director, National Center on Birth Defects and Developmental Disabilities The Federal Response to COVID -19: Addressing the Needs of the Autism and Disability Communities National Institute of Mental Health28 April 2021 Updates on vaccine recommendations and timelineCurrently authorized vaccines Pfizer -BioNTech Moderna Johnson & Johnson/Janssen All three vaccines were tested in tens of thousands of adults from diverse backgrounds, including older adults and communities of color. All of the available vaccines have been proven effective at preventing serious illness, hospitalization, and death from COVID -19. It is unknown how long protection from vaccines might last.mRNA vaccines Require two doses Viral vector equity for people with disabilities To help the United States succeed against COVID -19, federal, state, local, and tribal partners and community -serving organizations are working together to ensure all public health actions address health disparities for all populations.Populations of focus: Racial and ethnic minority populations People living in rural or frontier areas People experiencing homelessness Essential and frontline workers People with disabilities People with substance use disorders People who are justice- involved https://www.cdc.gov/coronavirus/2019 -ncov/community/health -equity/HE-in -action.htmlIntersection of disabilities and special healthcare needs Social relationships Vision MovementThinking Remembering Learning CommunicatingHearing Mental healthUnderlying medical conditionsBirth defectsDevelopmental disabilitiesAcquired disabilities May affect various activities or domainsCOVID- 19 Vaccination Accessibility CDC is working with partners across the country on implementation ofvaccination plans for their respective areas . CDC playbook was developed to provide important information for jurisdictions to consider when vaccinating people with disabilities . Vaccinating older adults and people -19/clinical -considerations/older -adults - and-disability/access.html Vaccinating https://www.cdc.gov/vaccines/covid -19/clinical -considerations/older -adults - and-disability.htmlAvailable Accessible COVID- 19 Resources Resources about COVID -19 for people with limited English and that are easy - to-read or in American Sign Language CDC Foundation supported the GA Institute of Technology (GA Tech) to translate COVID -19resources into accessible formats Ongoing development of repository ofaccessible COVID -19 vaccine information Source: https://www.cdc.gov/coronavirus/2019-ncov/communication/toolkits/people -with -disabilities.htmlPhoto source: CDC YouTube site White House Virtual Forum: Breaking Down Barriers for People Who Have Challenges Accessing COVID- 19 Vaccination (April 21, 2021) Supporting People with Autism Spectrum Disorder and Related Disabilities Partner organizations disseminating disability -related vaccine guidance and accessible documents Autism Science Foundation Autistic Self Advocacy Network Autism Speaks Autism Society Other organizations such as AAP , AAHD, AAPD, Toolkit with COVID -19 vaccine equity and prevention guidance Promising Practices : Reaching Populations with Limited Access to Vaccines Prioritizing and Scheduling People with Disabilities and Caregivers for Vaccination Study to Explore Early Development COVID -19 impacts including -Education and use of remote learning; use of services and telemedicine; testing and mitigation strategies; and changes in routines and well -being. -Changes in household structure, finances, employment and health insurance; and COVID- 19 infection -Pre-COVID -19 and post -COVID -19 assessment of behavior problems CDC longitudinal study of children aged 3-9 with autism spectrum disorder, other developmental disabilities, and in the general population who participated at ages 2 -5Considerations for pediatric populations and children with disabilities and special healthcare needsAdapted from source: Emily Erbelding, M.D., M.P.H. Director, Division of Microbiology and DesignmRNA: stabilized doses 30 \u00b5g 21 days apartIM 2 doses 100 \u00b5g 28 days apartIM 1 dose at 5 x 10 10 vp (also testing 2 doses (0, 56 days))IM 2 doses at 5 \u00d71010 vp (0, 28 days) Current Status Emergency Use Authorization (EUA) ages 16 and upEUA ages 18 and up EUA ages 18 and up Phase 3 adults Adolescents Fully enrolled Fully enrolled Start 4 -6wks after results from adult trialsTBD Younger Children Studies have begun Studies have begun TBD TBD Vaccine clinical development: children Routine vaccines widely available to pediatric populations Children receive routine vaccinations according to the recommended schedule. The Vaccines for Children (VFC) program provides vaccines at no cost to children who might not otherwise be vaccinated because of inability to pay. Approximately half of U.S. children are eligible for VFC and ~86% of U.S. pediatricians provide care in a -enrolled practice. https://www.cdc.gov/vaccines/parents/schedules/index.htmlWhitney CG, Zhou F, Singleton J, Schuchat A. Benefits from immunization during the Vaccines for Children program era\u2014 United States, 1994 -2013. Vogt T, et al. Pediatricians' experiences with and perceptions of the Vaccines for Children program. Pediatrics 2020;145:1204 -7. https://www.cdc.gov/vaccines/parents/schedules/index.htmlConsiderations for ensuring equity to vaccine access for children with disabilities or other healthcare needs It is important that people with disabilities get the COVID -19 vaccine. Some children may have more interaction with trusted healthcare or service specialists than with general pediatricians. -Pediatric hospital systems -Pediatric specialists and/or disability -specific practices and clinics -Occupational, physical, or speech specialists Vaccinating children with disabilities and special healthcare needs, their caregivers, family members (e.g., parents and siblings), and service providers as soon as they can to reduce risk of negative outcomes from COVID -19. Vaccination sites and providers and vaccination messaging should be accessible to all populations with disabilities. https://www.cdc.gov/coronavirus/2019 -ncov/vaccines/recommendations/disabilities.htmlFor more information, contact The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. "}